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Development/Plasticity/Repair

AMPA-Kainate Receptor Inhibition Promotes Neurologic
Recovery in Premature Rabbits with Intraventricular
Hemorrhage
Preeti Dohare,1 Muhammad T. Zia,1,2 Ehsan Ahmed,1 Asad Ahmed,1 Vivek Yadala,1 Alexandra L. Schober,3
Juan Alberto Ortega,4 Robert Kayton,5 Zoltan Ungvari,6 Alexander A. Mongin,3 and Praveen Ballabh1,2
Departments of 1Pediatrics and 2Cell Biology and Anatomy, Regional Neonatal Center, Maria Fareri Children’s Hospital at Westchester Medical Center-New
York Medical College, Valhalla, New York 10595, 3Center for Neuropharmacology and Neuroscience, Albany Medical College, Albany, New York 12208,
4Department of Neuroscience, University of Connecticut Health Center, Farmington, Connecticut 06030, 5Department of Physiology and Pharmacology,
Oregon Health and Science University, Portland, Oregon 97239, and 6Reynolds Oklahoma Center on Aging, and Department of Geriatric Medicine,
University of Oklahoma Health Science Center, Oklahoma City, Oklahoma 73104

Intraventricular hemorrhage (IVH) in preterm infants leads to cerebral inflammation, reduced myelination of the white matter, and
neurological deficits. No therapeutic strategy exists against the IVH-induced white matter injury. AMPA-kainate receptor induced
excitotoxicity contributes to oligodendrocyte precursor cell (OPC) damage and hypomyelination in both neonatal and adult models of
brain injury. Here, we hypothesized that IVH damages white matter via AMPA receptor activation, and that AMPA-kainate receptor
inhibition suppresses inflammation and restores OPC maturation, myelination, and neurologic recovery in preterm newborns with IVH.
We tested these hypotheses in a rabbit model of glycerol-induced IVH and evaluated the expression of AMPA receptors in autopsy
samples from human preterm infants. GluR1-GluR4 expressions were comparable between preterm humans and rabbits with and
without IVH. However, GluR1 and GluR2 levels were significantly lower in the embryonic white matter and germinal matrix relative to the
neocortex in both infants with and without IVH. Pharmacological blockade of AMPA-kainate receptors with systemic NBQX, or selective
AMPA receptor inhibition by intramuscular perampanel restored myelination and neurologic recovery in rabbits with IVH. NBQX
administration also reduced the population of apoptotic OPCs, levels of several cytokines (TNF␣, IL-␤, IL-6, LIF), and the density of
Iba1 ⫹ microglia in pups with IVH. Additionally, NBQX treatment inhibited STAT-3 phosphorylation, but not astrogliosis or transcription factors regulating gliosis. Our data suggest that AMPA-kainate receptor inhibition alleviates OPC loss and IVH-induced inflammation and restores myelination and neurologic recovery in preterm rabbits with IVH. Therapeutic use of FDA-approved perampanel
treatment might enhance neurologic outcome in premature infants with IVH.
Key words: AMPA; myelination; NBQX; oligodendrocyte; perampanel

Significance Statement
Intraventricular hemorrhage (IVH) is a major complication of prematurity and a large number of survivors with IVH develop
cerebral palsy and cognitive deficits. The development of IVH leads to inflammation of the periventricular white matter, apoptosis
and arrested maturation of oligodendrocyte precursor cells, and hypomyelination. Here, we show that AMPA-kainate receptor
inhibition by NBQX suppresses inflammation, attenuates apoptosis of oligodendrocyte precursor cells, and promotes myelination
as well as clinical recovery in preterm rabbits with IVH. Importantly, AMPA-specific inhibition by the FDA-approved perampanel,
which unlike NBQX has a low side-effect profile, also enhances myelination and neurological recovery in rabbits with IVH. Hence,
the present study highlights the role of AMPA-kainate receptor in IVH-induced white matter injury and identifies a novel strategy
of neuroprotection, which might improve the neurological outcome for premature infants with IVH.
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Introduction
Intraventricular hemorrhage (IVH) remains the most common
neurological complication of prematurity that results in neurodevelopmental consequences, including cerebral palsy, cognitive
deficits, and mental retardation (Ballabh, 2010). No therapeutic
or preventive strategy exists for the white matter injury in premature infants with IVH. Because AMPA-kainate receptor activation reduces myelination in several paradigms of brain injury
(Fern and Möller, 2000; Deng et al., 2003; Follett et al., 2004;
Kanwar et al., 2004), we asked whether AMPA-kainate glutamate
receptor stimulation would induce white matter injury in survivors with IVH.
IVH develops predominantly in preterm infants of 22–32 gestational weeks. During this period, oligodendrocyte progenitor
cells (OPCs) are in a process of specification and maturation.
Three successive stages of oligodendrocytes have been identified,
including the late OL progenitor (preoligodendrocytes), the immature OL, and the mature OL. Preoligodendrocytes (premyelinating cells) are the most abundant in preterm infants of 22–32
gestational weeks, and myelinating (immature OPCs) oligodendrocytes are progressively increasing in number after 28 –32 gestational weeks (Back et al., 2001). Preoligodendrocytes are more
vulnerable to hypoxia-ischemia and glutamate receptormediated toxicity compared with myelinating OPCs (Fern and
Möller, 2000; Back et al., 2002; Itoh et al., 2002; Deng et al., 2003).
These OPCs are known to express AMPA (glutamate receptors
1– 4 [GluR1-GluR4]) and kainate (GluR5-GluR7 and KA1–2)
receptors (Gallo et al., 1994; Rosenberg et al., 2003). AMPA receptors are tetrameric ligand-gated ion channels located on the
postsynaptic membrane that mediate glutamatergic excitatory
transmission. The presence of GluR2 subunits renders AMPA
receptors impermeable to calcium ions (Verdoorn et al., 1991;
Geiger et al., 1995). All the GluR subtypes are expressed in OPCs;
however, their expressions vary during development and with
brain region (Fern and Möller, 2000; Rosenberg et al., 2003). The
presence of GluR1, GluR3, and GluR4 subunits makes particularly OPCs susceptible to excitotoxic damage during development because Ca 2⫹ influx through these receptors triggers a
cascade of injury.
A number of studies have evaluated AMPA receptors in models of hypoxia-ischemia, cerebral trauma, and multiple sclerosis
and have reported neuroprotection with blockade of AMPAkainate receptors (Pulsinelli et al., 1982; Choi, 1995; Tanaka et al.,
2000; Goda et al., 2002; Groom et al., 2003). Global hypoxiaischemia reduces both mRNA and protein expression of
GluR2 subunit, and this reduction enhances Ca 2⫹ permeability
of AMPA receptors in neurons and glia during the insult
(Pellegrini-Giampietro et al., 1992). Moreover, glutamate accumulates in perisynaptic spaces under hypoxic-ischemic conditions, thereby activating AMPA receptors and eliciting glutamate
excitotoxicity. Rodent OPCs primarily express AMPA and kainate receptors, but not the NMDA receptors (Gallo et al., 1994;
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nists inhibit calcium mediated excitotoxicity and cell death in
OPC culture model of oxygen-glucose deprivation (Fern and
Möller, 2000; Yoshioka et al., 2000; Deng et al., 2003). Consistent
with this, NBQX, an AMPA-kainate receptor antagonist, treatment restores myelination in a neonatal rat model of hypoxiaischemia (Follett et al., 2004). More importantly, glutamate
excitotoxicity is thought to be a major contributor to hypomyelination in human preterm infants (Volpe, 2009a). Despite this,
the role of glutamate excitotoxicity in IVH-induced white matter
injury and therapeutic benefits of AMPA-kainate receptor inhibition in restoring myelination have remained unexplored.
Our previous studies have shown that IVH induces robust
inflammation in the periventricular white matter, leading to microglial infiltration, oxidative stress, and elevation in proinflammatory cytokines, TNF␣, IL-1␤, and astrogliosis (Georgiadis et
al., 2008; Chua et al., 2009; Vinukonda et al., 2010). JAK-STAT
signaling are key regulators of inflammation and cell survival.
STAT3 is expressed by both oligodendrocytes and astrocytes in
the CNS (Cattaneo et al., 1999) and is involved in the astrocytic
differentiation and astrogliosis (Herrmann et al., 2008). Based on
these considerations, we hypothesized that IVH would activate
AMPA receptors and that AMPA-kainate (NBQX) or AMPA
(perampanel) receptor inhibition might suppress inflammation
and restore OPC maturation, myelination as well as clinical recovery in preterm rabbit pups with IVH. We also postulated that
NBQX treatment might reduce astrogliosis through inhibition of
JAK-STAT signaling.

Materials and Methods
Animals. This study was performed with approval from the Institutional
Animal Care and Use Committee of New York Medical College (Valhalla, NY). We used a preterm rabbit model of glycerol-induced IVH that
has been extensively validated in our prior studies (Chua et al., 2009;
Vinukonda et al., 2010; Vose et al., 2013). Timed-pregnant New Zealand
rabbits were purchased from Charles River Laboratories. We performed
C-section to deliver the premature pups at 29 d of gestational age (fullterm ⫽ 32 d). Newborn pups were reared in an infant incubator at a
temperature of 35°C. We used rabbit milk replacer (Zoologic, PetAg) to
gavage-feed the pups in a volume of ⬃2 ml every 12 h (100 ml/kg/d) for
the first 2 d, and feeds were advanced to 125,150, 200, 250, and 280 ml/kg
at postnatal days 3, 5, 7, 10, and 14, respectively. We treated rabbit pups
of either sex with 50% intraperitoneal glycerol (6.5 g/kg) at 4 h of age to
induce IVH. Severity of IVH was evaluated by measuring ventricle volume (length, breadth, and depth in coronal and sagittal views) on head
ultrasound at 24 h age using an Acuson Sequoia C256 (Siemens) ultrasound machine. Pups with IVH were grouped as moderate (70 –150
mm 3) and severe (151–250 mm 3) IVH, based on ventricular volume (see
Fig. 1A). Ventricular volume ⬍70 mm 3 indicated either an absence of
IVH or presence of microscopic hemorrhage. Intraperitoneal glycerol
induces intraventricular hemorrhage by causing intravascular dehydration, increase in serum osmolality, consequent decline in intracranial
pressure, and rupture of fragile vessels in the ganglionic eminence (Ballabh et al., 2007; Georgiadis et al., 2008). The pups with moderate and
severe IVH were assigned into treatment and control group so that the
severity of IVH was balanced between the comparison groups.
NBQX and perampanel treatment. The rabbit pups with IVH were
sequentially treated with either intramuscular vehicle (saline) or NBQX
(20 l, 15 mg/kg) twice a day for 7 d, starting at day 1. The dose of NBQX
was calculated based on its previous use in a rodent model of hypoxiaischemia rats and in other models of cerebral injury (Jackson et al., 1998;
Jensen, 2005). The severity of IVH, measured by ultrasound, was similar
between the comparison groups: vehicle-treated pups with IVH and
NBQX-treated pups with IVH. In another set of experiments, rabbit pups
with moderate to severe IVH were sequentially treated with intramuscular perampanel (8 mg/kg) or saline once daily. The dose of perampanel
was based on its previous use in animal model and human clinical trials
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Table 1. Characteristics of human infants with and without IVH
Postconceptional
age (weeks)

Sex

Birth
weight (kg)

IVH/no IVH

Cause of death

26
23
23
24

Male
Male
Female
Male

0.810
0.57
0.58
0.64

IVH Grade 3
IVH Grade 2
IVH Grade 3
IVH Grade 4

24
23
23
25

Male
Female
Female
Female

0.6
0.52
0.53
0.71

IVH Grade 4
IVH Grade 3
No IVH
No IVH

23

Male

0. 45

No IVH

24
25

Male
Male

0.61
0.73

No IVH
No IVH

24

Female

0.56

No IVH

Clinical sepsis
Clinical sepsis
Respiratory failure
Pulmonary
hemorrhage
Clinical sepsis
Respiratory failure
Respiratory failure
Metabolic acidosis,
respiratory failure
RDS, respiratory
failure
Clinical sepsis
Metabolic acidosis,
respiratory failure
Respiratory failure

RDS, Respiratory distress syndrome.

(Russo et al., 2012; Hanada et al., 2014). Rectal temperature was monitored for the pups during the first 3 d using rectal probe.
Human subjects. The Research Administration of New York Medical
College (Valhalla, NY) approved the use of autopsy brain samples from
premature infants for the present study. The postmortem materials included forebrain tissue samples harvested from premature infants with
and without IVH of 23–26 gestational weeks. These infants were of ⬍5 d
of postnatal age (Table 1), and the postmortem samples were obtained
within 18 h of their demise. We excluded premature neonates with
hypoxic-ischemic encephalopathy, meningitis, culture proven sepsis,
major brain or spinal cord malformation, and chromosomal defects. We
included 6 preterm infants from each group (IVH and no IVH). The wall
of the cerebral hemisphere in premature infants consists of ventricular
zone, subventricular zone, intermediate zone, cortical plate, and marginal zone as illustrated by the Boulder Committee (Bystron et al., 2008).
In this manuscript, we used the term intermediate-zone embryonic white
matter interchangeably with white matter, ganglionic eminence with germinal matrix, and cerebral cortex with cortical plate.
Rabbit tissue collection and processing. We processed the tissues as described previously (Ballabh et al., 2007). The brain slices were immersed
into 4% PFA in PBS (0.1 M, pH 7.4) overnight and then were cryoprotected by keeping them into 15% sucrose in 0.1 M PBS buffer for 24 h
followed by 30% sucrose for the next 24 h. We then froze the tissue slice
after embedding into optimum cutting temperature compound
(Sakura). Frozen coronal blocks were cut on a cryostat into coronal
sections of 20 m thickness. For Western blot analyses, 1- to 2-mm-thick
coronal slice was harvested at the level of the midseptal nucleus and
snap-frozen on dry ice.
Human tissue collection and processing. We processed the human tissues as in our previous studies (Ballabh et al., 2007). Coronal slices of 3– 4
mm thickness were taken at the level of head of caudate nucleus from the
frontoparietal lobe. The coronal blocks consisted of cortical plate, embryonic white matter, and ganglionic eminence. The samples were
immersion-fixed into 4% PFA in PBS for 12–18 h and were then cryoprotected by immersing into a 15% sucrose solution in PBS, followed by
30% sucrose in PBS. The tissues were next frozen after embedding them
into optimum cutting temperature compound (Sakura). Frozen coronal
blocks were cut into sections of 20 m thickness. For Western blot analyses, pieces of tissues were directly harvested from the cortex, white matter, and ganglionic eminence into Eppendorf tubes and were snap-frozen
on dry ice.
Immunohistochemistry. Immunohistochemical staining was performed as described previously (Ballabh et al., 2007). The primary antibodies used in experiments included the following: rabbit GluR1 (catalog
#13185, Cell Signaling), rabbit GluR2 (catalog #ab1506, Millipore), rabbit GluR3 (catalog #4676, Cell Signaling), rabbit GluR4 (catalog #8070,

Cell Signaling), goat polyclonal Ki67 (catalog #275R-14, Cell Marque),
goat polyclonal Olig2 (catalog #AF-2418, R&D Systems), mouse monoclonal GFAP (catalog #G6171, Sigma-Aldrich), mouse monoclonal myelin basic protein (MBP; catalog #ab62631, Abcam), goat polyclonal
PDGFR␣ (catalog #AR307, R&D Systems), mouse monoclonal myelinassociated glycoprotein (MAG; catalog #AB89780, Abcam), mouse
monoclonal Stat 3 (catalog #9139, Cell Signaling Technology), rabbit
pStat3 (tyrosine 705, catalog #9145, Cell Signaling Technology), mouse
pStat3 (serine 727, catalog #9136, Cell Signaling Technology), mouse
NKX2.2 (Developmental Studies Hybridoma Bank, University of Iowa),
goat Iba1 (catalog #5076, Abcam), rabbit polyclonal NFIA (catalog
#39397, Active Motif), rabbit polyclonal Sox9 (catalog #ab5535, Millipore), and sheep polyclonal Notch intracellular domain (NICD) (catalog
#AF3647, R&D Systems). Secondary antibodies used were Cy-3 conjugate donkey anti-mouse, Cy-3 conjugate donkey anti-goat, and FITC
conjugate donkey anti-rat (Jackson ImmunoResearch Laboratories).
Briefly, we hydrated the fixed sections in 0.1 M PBS, blocked the sections
with normal donkey serum in PBS with 0.01% Triton-X (PBST), and
incubated with the primary antibodies diluted in PBST at 4°C overnight.
After several washes in PBS, the sections were incubated with secondary
antibody diluted in 1% normal goat serum in PBS at room temperature
for 60 min. Finally, after washing in PBS, sections were mounted with
Slow Fade Light Antifade reagent (Invitrogen) and were visualized under
a Confocal microscope (Nikon Instruments). Stereology was performed
using a fluorescent microscope (Axioskop 2 plus, Carl Zeiss) with motorized
specimen stage for automated sampling (ASI), CCD color video camera
(Microfire, Optronics), and stereology software (Stereologer, SRC).
Fluorescent in situ detection of DNA fragmentation (TUNEL). We performed TUNEL staining on fixed brain sections as described previously
(Dummula et al., 2011). For TUNEL staining, tissue sections of 12 m
thickness were air dried on slides, hydrated in 0.01 M PBS, and permeabilized for 5 min in 1:1 ethanol/acetic acid. An ApopTag-fluorescein in
situ DNA fragmentation detection kit (catalog #S7110, Millipore) was
used to visualize TUNEL-labeled nuclei.
Quantification of oligodendrocytes. Proliferation and maturation of
OPCs were assessed in the corona radiata and corpus callosum of pups
without IVH and pups with IVH treated with vehicle or NBQX. Cycling
OLs were identified by double-labeling the coronal sections with Olig2
and Ki67 antibodies, whereas maturation of OLs was evaluated by
double-labeling the sections with Olig2 and Nkx2.2 antibodies. All coronal sections were obtained at the level of the midseptal nucleus (five 20
m sections collected at 60 m interval). Quantification was performed
by a blinded investigator in a random, unbiased fashion using a confocal
microscope with a 60⫻ lens (Nikon Instruments). Cells were counted in
⬃25 images (5 images ⫻ 4 –5 sections) for each brain region for every
parameter for each pup (n ⫽ 5 pups per group).
Stereological assessment of myelin and astrocytes in the white matter. We
quantified a number of stereological parameters using computerized
software system (Stereologer, Stereology Resource Center). Briefly, 30m-thick coronal sections were cut on a cryostat with a section sampling
interval of 90 m to achieve ⱖ6 sections at the level of mid-septal nucleus. The sections were double-labeled with MBP antibody and DAPI
(nuclear stain) and quantified as follows. The reference spaces (corona
radiata, corpus callosum) were outlined on the section ⬍5⫻ objective.
The volume of the outlined area (reference space) was quantified using a
point counting probe (frame 25 m ⫻ 25 m; guard zone 2 m, interframe interval ⫽ 300 m). The total volume fraction (load) of myelin
stained by MBP antibody through a defined reference space was estimated using the object area fraction probe ⬍60⫻ oil lens. For the area
fraction probe (frame 25 m ⫻ 25 m; guard zone 2 m, interframe
interval 400 m), the user clicked on the grid points that overlapped the
myelin fibers in sections labeled with MBP. The area fraction of myelination was quantified as the ratio of product of the area per point and
number of points hitting reference area the over the product of the area
per point and number of points hitting the sampled area [a(point)䡠
冱Psamp], as reported previously. A coefficient of error ⬍0.10 was considered acceptable. To assess gliosis, we quantified total volume fraction of
astrocyte cell body and glial fibers in a similar manner as for myelin
(Mouton et al., 2009).
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Western blot analyses. We homogenized the frozen brain tissue in a
sample buffer (3% SDS, 10% glycerol, and 62.5 mM Tris-HCl) using a
mechanical homogenizer and then sonicated the lysate before centrifugation. Supernatant protein concentration was measured using a BCA
protein assay kit (Pierce, kit #23227, Thermo Scientific), and dilutions of
BSA were used to create a standard curve. After boiling the samples in
Laemmli buffer (catalog #161-0737, Bio-Rad), total protein samples
were separated by SDS-PAGE (Vinukonda et al., 2010). Equal amounts
of protein (10 –20 g) were loaded onto 4%–15% or 4%–20% gradient
precast gels (Bio-Rad), based on the molecular weight of the target protein. Separated proteins were transferred onto PVDF membrane by
electro-transfer. Membranes were then incubated overnight with primary antibodies. We detected target proteins with chemiluminescence
ECL system (GE Healthcare) by using secondary antibodies conjugated
with HRP (Jackson ImmunoResearch Laboratories). We stripped the
membrane using stripping buffer (2.5% SDS, 0.7% 2-mercaptoethanol,
62.5 mM Tris-HCl, pH 6.8) and then incubated with ␤-actin antibody
(catalog #A5316, Sigma) followed by secondary antibody and detection
with chemiluminescence ECL system. As described previously (Vinukonda et al., 2010), the blots from each experiment were densitometrically analyzed using ImageJ, and optical density (OD) values for each
protein of interest were normalized to those of ␤-actin. Antibodies used
for Western blot analyses were the same as for immunohistochemistry.
Calcium signaling studies. OPCs were isolated from E29 rabbit brain, as
described previously (Ortega et al., 2013). Briefly, whole forebrain tissue
was harvested from an anesthetized rabbit pup. The brain was mechanically dissociated in 0.025% trypsin-EDTA solution. OPCs were then
isolated from the homogeneous cell suspension using anti-O4 microbeads (Magnetic Activated Cell Sorting protocol, Miltenyi Biotec),
and ⬃100,000 –150,000 cells per coverslip were plated. The OPCs were
cultured for 3 d in expansion medium at 37°C. The cells were loaded with
Fluorforte (ENZ-51017, Enzo Life Sciences) for 60 min at room temperature per the manufacturer’s instructions. To assess AMPA-kainatemediated Ca 2⫹ uptake, cells were incubated with NBQX (20 M) or
vehicle and then were treated with plasma. After 40 min of incubation,
the images were acquired at identical settings using Nikon confocal microscope, and fluorescence intensity was calculated using NIS software
(Nikon).
qRT-PCR. Gene expression was quantified by real-time PCR, as described previously (Ballabh et al., 2007). Briefly, total RNA was isolated
using a RNeasy Mini kit (catalog #74104, QIAGEN) from a coronal brain
slice taken at the level of the mid-septal nucleus. cDNA was synthesized
using Superscript II RT enzyme (catalog #05081955001, Roche) followed
by a real-time quantitation using an ABI Prism 7900HT detection system. TaqMan probes were bought from Invitrogen. Their assay IDs were as
follows: GAPDH (Oc03823402_g1), GRIA1 (Hs00990746_m1), GRIA2
(Hs00968358_m1), GRIA3 (Hs01557466_m1), GRIA4 (Hs00898778_m1),
TNF␣ (Oc03397716_g1), IL1␤ (Oc03823250_s1), CNTF (Oc0339
7817_m1), LIF (Hs01055668_m1), IL-6 (Oc04097053_m1), and interferon-␥ (Oc04096817_m1).
Electron microscopy. We processed brains (14 d) from the glycerol
treated rabbit pups without IVH, pups with IVH, and the NBQX-treated
pups with IVH (n ⫽ 3 or 4 each). We took coronal slices (2 mm thickness) from freshly harvested rabbit pup brain using a brain slicer matrix
and then dissected corona radiata and corpus callosum in a Petri dish
under a SteReo discovery microscope (Carl Zeiss). The tissue samples
from the white matter were fixed into 2.5% glutaraldehyde overnight.
The tissue samples were then washed in 0.1 M sodium cacodylate buffer,
pH 7.4, postfixed in buffered osmium tetroxide for 1–2 h, stained en bloc
with 1% uranyl acetate, dehydrated in graded ethanol solutions, and then
embedded in epoxy resin. We placed sections of 60 –90 nm thicknesses
onto 200 mesh grids, stained with uranyl acetate and lead citrate, and
then examined with a Techni 12 electron microscope at 80 kV. For each
brain, we acquired 12–20 digital images using a 16 megapixel camera
(Advanced Microscopy Techniques). Electron micrographs were assessed for myelinated axons per unit area; and the g-ratio (ratio of axonal
diameter with myelin sheath to the axonal diameter without myelin
sheath) of myelinated axons were computed in the three groups of pups
using ImageJ (National Institutes of Health).

HPLC analysis of amino acid content in CSF samples. The CSF samples
were snap-frozen on dry ice and stored at ⫺80°C until the day of HPLC
assay. Samples were thawed on ice and immediately deproteinated using
ice-cold methanol (1:4). After 15 min incubation on ice, samples were
clarified by centrifugation (15,000 ⫻ g for 15 min). The supernatants
were removed and analyzed for amino acid content using a 1200 HPLC
setup with fluorescence detector (Agilent Technologies) as previously
described (Dohare et al., 2014). Briefly, the amino acid levels were quantified after derivatization with o-phthalaldehyde in the presence of
␤-mercaptoethanol. The derivatives were separated on an Eclipse
XDB-C18 HPLC column, and fluorescence intensities of separated products were compared with the calibration standards of L-glutamate,
L-glutamine, taurine and L-alanine.
Statistics and analysis. Data are presented as mean ⫾ SEM. To compare
the levels of MBP, MAG, CNPase, and cytokines as well as cell counts
between three groups (no IVH, vehicle, and NBQX or perampaneltreated pups), we used one-way ANOVA. To assess the difference in the
protein and mRNA expression of glutamate receptors between pups with
and without IVH at 24 and 72 h age, we used two-way ANOVA with
repeated measures. Likewise, protein expression of GluR1-GluR4 in the
three brain regions (cortex, white matter, and germinal matrix) in preterm infants with and without IVH was compared using two-way
ANOVA with repeated measures. The repeated factor was applied to the
three brain regions: ganglionic eminence, white matter, and cortex. All
post hoc comparisons between means were done by Tukey multiplecomparison test at 0.05 significance.

Results
IVH does not affect glutamate receptor expression in rabbits
and humans
To determine whether IVH affects the expression of AMPA receptor subunits, GluR1-GluR4, in premature human infants
(postmortem) of 23–26 weeks gestational age, we labeled coronal
sections from the forebrain with GluR1-GluR4 specific antibodies. GluR1-GluR4 were abundantly expressed in the neocortical
mantle (cortex), embryonic white matter, and germinal matrix of
preterm infants (data not shown). GluR1 was expressed on a
number of O4 ⫹ OPCs in the white matter and germinal matrix,
however weakly on GFAP ⫹ radial glia of the germinal matrix and
astrocytes of the white matter. GluR2 reactivity was observed on
both O4 ⫹ OPCs and GFAP ⫹ astrocytes as well as on radial glia.
GluR3 and GluR4 were abundantly expressed on GFAP ⫹ astrocytes and on a few O4 ⫹ oligodendrocytes. The expression of
GluR1-GluR4 was weak to absent on MAP2 ⫹ neuronal progenitors in the germinal matrix; however, they were abundantly expressed on the cortical neurons. Overall, immunoreactivity of
GluR1-GluR4 in the cortex, white matter, and germinal matrix
was comparable between preterm infants with and without IVH.
However, comparison between the brain regions revealed that
GluR1-GluR2 immunoreactivity was relatively lower in the white
matter and germinal matrix compared with the cortex. Western
blot analyses confirmed that GluR1-GluR4 levels were similar
between infants with and without IVH in the three brain regions
(Fig. 1C). However, GluR1 and GluR2 were reduced in the white
matter and germinal matrix compared with the cortex in both
infants with IVH and without IVH ( p ⬍ 0.001, all).
We next evaluated the protein expression of GluR1-GluR4 in
the forebrain of preterm rabbits (E29) with IVH versus without
IVH at 48 and 72 h postnatal age by Western blot analyses (Fig.
2A). There was no significant difference in the levels of these
receptors between pups with and without IVH. Accordingly,
mRNA expression of GluR1-GluR4 was comparable in the forebrain of preterm rabbits with and without IVH at both postnatal
day 3 (D3) and day 7 (D7) (Fig. 2B). There was no significant
interval change in the expression of these receptors. Together, the
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Figure 1. IVH in rabbit brains and AMPA receptor subunits in premature human infants. A, Coronal brain slice taken from frontal lobe of E29 rabbit pup, which shows normal slit-like ventricle
(arrowhead), moderate hemorrhage in the ventricle (middle panel), and severe hemorrhage resulting in fusion of the two ventricles (block arrows). Scale bar, 1 cm. B, Coronal and sagittal views of
head ultrasound of rabbits with (bottom) and without IVH (top). Arrow indicates slit-like ventricle in pups without IVH. Arrowhead indicates large IVH. C, Western blot analysis for AMPA receptor
subunits GluR1-GluR4 in the brain tissue from preterm human infants with and without IVH. Data are mean ⫾ SEM (n ⫽ 5, each group). Protein expression values were normalized to the levels of
␤-actin. There was no significant difference in the expression of any GluRs between infants with IVH and without IVH. There are significantly reduced levels of GluR1 and GluR2 in the germinal matrix
and white matter relative to the cortex in both infants with and without IVH. ***p ⬍ 0.001, cortex versus germinal matrix or white matter in infants without IVH. ###p ⬍ 0.001, cortex versus
germinal matrix or white matter in infants with IVH.

development of IVH did not affect GluR1-GluR4 expression in
rabbit pups or human infants with and without IVH. However,
both GluR1 and GluR2 were reduced in the periventricular germinal matrix and embryonic white matter relative to the cortex of
premature infants. A reduction in GluR2 might render these
brain regions more vulnerable to glutamate-induced toxicity.
Glutamate levels in the CSF showed a trend toward increase
in rabbits with IVH
Glutamate has a pivotal role in neurological disorders, and its
levels are increased in cerebral ischemia, trauma, and degenerations (Dávalos et al., 1997). Therefore, we postulated that glutamate might be increased in the pups with IVH. The cerebral
ventricles are filled with blood in these pups with IVH, and it is
gradually absorbed by days 3–5. To avoid blood contamination in
the samples and based on the feasibility in premature pups, we
assayed glutamate in CSF obtained from cisterna magna puncture at D3 and D7. The glutamate levels were measured by highperformance chromatography in the CSF of (1) rabbits without
IVH (no glycerol), (2) glycerol-treated rabbits without IVH, and
(3) glycerol-treated rabbits with IVH. The mean levels of CSF

glutamate in pups with IVH was twofold to threefold higher compared with pups without IVH (no glycerol) and approximately twofold higher relative to glycerol-treated pups without IVH (Fig. 2C).
However, these comparisons were not statistically significant. The
CSF levels of two major extracellular amino acids (glutamine and
alanine) were similar between the three sets of pups (data not
shown), suggesting specificity of observed changes in CSF glutamate.
Some elevation in CSF glutamate levels in glycerol-treated pups
without IVH (relative to pups without glycerol treatment) can be
attributed to a failure of head ultrasound to detect microscopic
bleeds. Indeed, microscopic IVH after glycerol treatment can potentially induce some increase in CSF glutamate levels. Together, glutamate levels showed an insignificant trend toward increase in pups
with IVH, which is consistent with the studies in rat models of
hypoxia-ischemia (Vannucci et al., 1999).
NBQX treatment restores myelination in rabbit pups
with IVH
Because AMPA-kainate activation mediates oligodendrocyte
death and inhibits maturation of OPCs as well as myelination in
models of hypoxia-ischemia (Follett et al., 2000, 2004; Volpe,
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Figure 2. IVH does not affect glutamate receptor expression in preterm rabbits. A, Representative Western blot analysis of the AMPA receptor subunits GluR1-GluR4 in the brain tissue from
preterm rabbits with and without IVH at postnatal age 48 and 72 h. Adult rat brain was used as positive control. Data are mean ⫾ SEM (n ⫽ 5 each). Values were normalized to ␤-actin. There was
no significant difference in the expression of GluRs between pups with IVH and without IVH. B, Data are mean ⫾ SEM (n ⫽ 5 each group). Bar charts represent mRNA expression of GluR1-GluR4
(GRIA 1– 4). The mRNA expression for these receptors was comparable between pups with and without IVH at both D3 and D7. C, CSF glutamate levels show a trend toward increase in pups with IVH
relative to controls; however, there was no significant difference in CSF glutamate levels between pups with and without IVH at D3 and D7. Glyc, Glycerol.

2009b), we evaluated the effect of AMPA-kainate receptor inhibition on myelination in rabbits with IVH. To this end, we compared myelination among three groups of pups at D14: (1)
glycerol-treated pups without IVH, (2) vehicle-treated pups with
IVH, and (3) NBQX-treated pups with IVH. To clarify, intraperitoneal glycerol was used to induce IVH, and intramuscular vehicle was administered for comparison with intramuscular NBQX.
Severity of IVH was comparable between vehicle- and NBQXtreated groups, as measured by head ultrasound. Stereological
quantification of MBP in immunostained sections revealed that
the volume fractions (myelin load) of MBP in the corpus callosum and corona radiata were significantly less in pups with IVH
relative to controls without IVH ( p ⬍ 0.004) and that intramuscular NBQX enhanced the expression of MBP ( p ⫽ 0.031; Fig.
3A). Consistent with stereological analyses, Western blot analyses
demonstrated that MBP, MAG, and CNPase levels were reduced
in pups with IVH compared with controls without IVH ( p ⬍
0.01, p ⬍ 0.01, and p ⬍ 0.001, respectively) and that NBQX
treatment significantly increased MBP, MAG, and CNPase expression in pups with IVH ( p ⫽ 0.001, p ⫽ 0.011, and p ⫽ 0.001,
respectively; Fig. 3 B, C).
Ultrastructural evaluation of the corpus callosum and corona
radiata demonstrated that numbers of myelinated axons were

fewer in pups with IVH compared with controls without IVH
( p ⬍ 0.05; Fig. 3E) and that NBQX treatment significantly increased the density of myelinated axons in pups with IVH ( p ⬍
0.05). Moreover, the g-ratio was comparable in the three groups
of pups (0.71 ⫾ 0.008 vs 0.73 ⫾ 0.016 vs 0.71 ⫾ 0.01, in pups
without IVH, IVH with vehicle, and NBQX treatment, respectively). This suggests that AMPA-kainate inhibition restores myelination and the morphology of the myelin sheath in the white
matter of preterm rabbit pups with IVH.
NBQX administration restores neurological recovery
To determine whether NBQX treatment enhances neurological
recovery of preterm rabbits with IVH, we performed neurobehavioral assessments of three sets of preterm pups at D14 (Table
2), as previously described (Vinukonda et al., 2010; Vose et al.,
2013). Vehicle- and NBQX-treated groups were balanced with
respect to the severity of IVH. All glycerol-treated pups without
IVH were neurologically normal. In contrast, we found symmetric quadriparesis in 2 pups (18%), asymmetric quadriparesis
(left ⬎ right sided weakness) in one, and left leg weakness (monoparesis) in one in the vehicle-treated group. The pups with
quadriparesis were completely unable to walk, and pups with
monoparesis manifested with clumsiness in the gait. Among pups
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Figure 3. NBQX treatment restores myelination in rabbits with IVH. A, Representative immunofluorescent images of MBP in the corona radiata and corpus callosum of D14 pups. Data are mean ⫾
SEM (n ⫽ 8 each group). Volume fractions of MBP were higher in the corpus callosum and corona radiata of NBQX-treated pups compared with vehicle controls with IVH. Scale bar, 200 m. V,
Ventricular side. B, Typical Western blots for MBP expression in the forebrain of premature rabbit pups, as indicated, at D14. Adult rat brain was used as positive control. Each lane represents lysate
from a whole coronal slice taken at the level of midseptal nucleus of one brain. Bar chart represents mean ⫾ SEM (n ⫽ 5, each group). MBP expression was higher in NBQX-treated pups compared
with the vehicle controls. C, Representative Western blot analysis for MAG expression in the forebrain of pups as indicated at D14. Adult rat brain was used as positive control. Bar graph represents
mean ⫾ SEM (n ⫽ 8 each group). MAG expression was higher in NBQX-treated pups compared with vehicle controls. D, Western blot analysis for CNPase expression in the forebrain of pups as
indicated at D14. Bar graph represents mean ⫾ SEM (n ⫽ 5, each group). Similar to MBP and MAG, CNPase expression was higher in NBQX-treated pups compared with vehicle-treated controls. E,
Representative electron micrograph from rabbit pups with and without IVH, and pups with IVH treated with NBQX at D14. Myelinated axons were fewer in pups with IVH compared with controls
without IVH, and NBQX treatment significantly increased the number of myelinated axons in pups with IVH. *p ⬍ 0.05, **p ⬍ 0.01, ***p ⬍ 0.001, pups with versus without IVH. #p ⬍ 0.05, ##p ⬍
0.01, vehicle versus NBQX-treated pups with IVH. ###p ⬍ 0.001, vehicle versus NBQX-treated pups with IVH. Scale bar, 1 m. Glyc, Glycerol.

treated with NBQX, one pup (10%) showed quadriparesis and
the remaining pups were neurologically normal. The scores for
gait were significantly higher in NBQX-treated pups than in vehicle controls ( p ⬍ 0.05). The average distance walked in 60 s was
farther in NBQX-treated pups compared with vehicle controls
( p ⫽ 0.04). The percentage of pups showing the ability to hold
their position on a ramp pitched at 60° inclination for ⱖ20 s was
more in NBQX-treated pups compared with saline controls (90%
vs 64%). Scores for the righting reflex, forearm, and hind arm
movement were significantly better in NBQX-treated pups compared with vehicle controls ( p ⬍ 0.05, for all). There was no
difference in sensory and cranial nerve assessment of the three
sets of rabbit pups. Importantly, we did not observe any apparent
adverse effect attributable to NBQX treatment among pups with
IVH receiving this medication. To test whether NBQX induces
hypothermia, rectal temperature was monitored in these three
sets of pups during the first 3 d, who were reared in an infant

incubator. There was no significant difference in the temperature
between groups, which ranged from 36°C to 37°C.
NBQX treatment reduces Ca ⴙ signaling, apoptosis, and
enhances maturation of OPC
Oxygen-glucose deprivation (simulating brain ischemia) of OPCs in
culture model activates Ca 2⫹-permeable AMPA-kainate receptors
(Deng et al., 2003). Because plasma has high glutamate levels and can
damage OPCs due to the presence of thrombin and other components (Juliet et al., 2009), we postulated that treating OPC with
plasma (simulating IVH) might enhance calcium influx in O4 ⫹
OPCs. To this end, we isolated pure population of O4 ⫹ cells from
the corona radiata and corpus callosum of E29 rabbits using Magnetic Activated Cell Sorting technology. We evaluated changes in
Ca 2⫹ content using membrane-permeable Ca 2⫹-sensitive fluorescent dye, FluoForte. Treatment of OPC with plasma significantly
increased FluoForte signal intensity (p ⬍ 0.01), and AMPA receptor
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Table 2. Neurobehavioral evaluation of NBQX- and vehicle-treated pups with IVH
and controls without IVH at the postnatal day 14a
System

Test

Cranial nerve

Aversive response to alcohol
Sucking and swallowing
Motor activity
Head
Fore legs
Hind legs
Righting reflexb
Locomotion on 30° inclinationc
Toned: forelimb
Toned: hindlimb
Inability to hold their position
at 60°
Inclination for ⱕ20 s (latency to
slip down the slope, if ⬍15 s)
Inability to walk ⬎60 inches
in 1 min (%)
Gaite
Motor impairmentf
Facial touch
Pain

Motor

Sensory

No IVH
(n ⫽ 11)

IVH vehicle
(n ⫽ 11)

IVH, NBQX
(n ⫽ 10)

3 (3, 3)
3 (3, 3)

3 (3, 3)
3 (3, 3)

3 (3, 3)
3 (3, 3)

3 (3, 3)
3 (3, 3)
3 (3, 3)
5 (5, 5)
3 (3, 3)
0 (0, 0)
0 (0, 0)
0%

3 (3, 3)
3 (1.25, 3)#
3 (1, 3)#
4 (0.5, 5)#
3 (1, 3)#
0 (0, 0)
0 (0, 0)
36%

3 (3, 3)
3 (3, 3)*
3 (3, 3)*
5 (5, 5)*
3 (3, 3)*
0 (0, 0)
0 (0, 0)
10%

0%

36%

10%

4 (4, 4)
0%
3 (3, 3)
3 (3, 3)

3 (1.5, 4)#
36%
3 (3, 3)
3 (3, 3)

4 (3.5, 4)*
10%
3 (3, 3)
3 (3, 3)

a

Values are median (interquartile range). Zero is the worst response and 3 is the best response, unless otherwise
noted.
b
Score (range, 1–5): no. of times turns prone within 2 s when placed in supine out of 5 tries.
c
Score (range, 0 –3): 0, does not walk; 1, takes a few steps (⬍8 inches); 2, walks for 9 –18 inches; 3, walks very well
beyond 18 inches.
d
Score (range, 1–3): 0, no increase in tone; 1, slight increase in tone; 2, considerable increase in tone; 3, limb rigid in
flexion or extension.
e
Gait was graded as follows: 0, no locomotion; 1, crawls with trunk touching the ground for few steps and then rolls
over; 2, walks taking alternate steps, trunk low, and cannot walk on inclined surface; 3, walks taking alternate steps,
cannot propel its body using synchronously the hind legs, but walks on 30° inclined surface; 4, walks, runs, and jumps
without restriction, propels the body using synchronously the back legs, but limitation in speed, balance, and
coordination manifesting as clumsiness in gait; 5, normal walking.
f
Motor impairment was defined as weakness in either fore legs or hind legs and distance walked ⬍60 inches in 60 s.
*p ⬍ 0.05, for vehicle-treated versus NBQX-treated pups with IVH.
#
p ⬍ 0.05, for glycerol-treated pups without IVH and vehicle-treated pups with IVH.

inhibition by NBQX treatment reduced the fluorescence intensity in
the OPCs (p ⬍ 0.05; Fig. 4A). This could be a mechanism by which
IVH may increase Ca 2⫹ influx into the OPCs to damage these cells in
our rabbit model.
We next asked whether NBQX treatment reduced apoptosis of
OPCs in rabbits with IVH. To this end, we double-labeled brain
sections for TUNEL and O4 antigen. We found that apoptotic
O4 ⫹ cells were significantly more abundant in the corpus callosum and corona radiata of pups with IVH compared with
glycerol-treated controls without IVH at D3 ( p ⬍ 0.01) and that
NBQX treatment substantially reduced the density of apoptotic
O4 ⫹ cells ( p ⫽ 0.004; Fig. 4B).
Because NBQX enhanced myelination in our glycerol model
of IVH, we postulated that NBQX treatment might affect proliferation and maturation of OPCs. To assess proliferation of OPC
in the corona radiata and corpus callosum, we compared cycling
and total PDGFR␣ ⫹ progenitor cell in glycerol-treated pups
without IVH, vehicle-treated, and NBQX-treated pups with IVH.
The densities of both total and cycling PDGFR␣ ⫹ cells showed a
trend toward reduction in pups with IVH compared with controls without IVH. However, the comparisons between the three
groups were not statistically significant (Fig. 4C).
We next evaluated the effect of NBQX treatment on OPC maturation in sections double-labeled with Olig2- and Nkx2.2-specific
antibodies. We found that Olig2 ⫹ OPCs were comparable between
the three groups. However, the population of Olig2 ⫹Nkx2.2 ⫹ cells

was significantly reduced in pups with IVH relative to controls without IVH (p ⫽ 0.006), and NBQX treatment significantly increased
their density (p ⫽ 0.04) in the corona radiata and corpus callosum
(Fig. 4D). This suggests that NBQX treatment restores the maturation of OPCs in pups with IVH. Consistent with this conclusion,
we found higher levels of CNPase (2⬘,3⬘-cyclic nucleotide-3⬘phosphodiesterase), as measured by Western blot analyses, in
NBQX-treated pups with IVH compared with vehicle controls (Fig.
3D) at D14. Together, NBQX treatment favors maturation of OPCs
but does not affect its proliferation.
NBQX suppresses microglia infiltration and
proinflammatory cytokines
As glutamate excitotoxicity might activate microglia and cerebral
inflammation (Volpe, 2009b; Kostic et al., 2013), we asked whether
IVH-induced cerebral inflammation and production of inflammatory mediators, and whether this can be alleviated by NBQX treatment. To this end, we quantified Iba1 ⫹ microglia in immunolabeled
sections and assayed mRNA expression of proinflammatory cytokines, including TNF␣, IL1␤, IL-6, LIF, CNTF, and interferon-␥, by
qRT-PCR using TaqMAN probes (Fig. 5).
We found that the development of IVH significantly increased
the density of Iba1 ⫹ microglia in both periventricular ganglionic
eminence and corona radiata ( p ⫽ 0.001 and p ⫽ 0.004, respectively) and, more importantly, NBQX treatment restored their
density ( p ⫽ 0.001, p ⬍ 0.05; Fig. 5 A, B). Consistent with these
findings, the onset of IVH led to an elevation in the expression of
TNF␣, IL1␤, IL-6, and LIF mRNA ( p ⫽ 0.004, p ⫽ 0.001, p ⫽
0.001, and p ⫽ 0.001, respectively) and NBQX treatment reduced
their levels ( p ⫽ 0.005, p ⫽ 0.035, p ⫽ 0.001, and p ⫽ 0.013,
respectively; Fig. 5C). However, the levels of interferon-␥ and
CNTF were neither elevated in pups with IVH nor reduced with
NBQX treatment. This suggests that IVH-induced inflammation
is significantly curtailed by NBQX treatment.
NBQX treatment does not affect astrogliosis
Because AMPA receptor inhibition alleviates Ca 2⫹-mediated excitotoxicity and cell death (Fern and Möller, 2000; Follett et al., 2004),
we reasoned that NBQX treatment might reduce astrogliosis. Hence,
we used stereological evaluation of immunostained sections and
Western blot analyses to compare GFAP expression between control
pups without IVH (glycerol treated), vehicle- and NBQX-treated
pups with IVH. We found that GFAP expression was elevated
in pups with IVH compared with controls without IVH at D14 (p ⫽
0.013 and p ⫽ 0.001 in stereology and Western blot analyses, respectively; Fig. 6A–C). However, there was no difference in the GFAP
expression between vehicle- and NBQX-treated pups with IVH.
GFAP expression was also elevated at D3 in pups with IVH compared with controls without IVH (p ⬍ 0.01).
Because NBQX treatment promotes myelination in pups
with IVH, we reasoned that this might influence myelination
or gliosis in healthy pups. Hence, we compared MBP and
GFAP levels in the vehicle- and NBQX-treated healthy pups at
D14 (data not shown). We found that NBQX treatment did
not significantly affect myelination or astrogliosis in healthy
pups without IVH.
NBQX blocks p-STAT3 signaling but does not affect
astrocyte proliferation
STAT-3 is a member of JAK-STAT signaling family, which triggers responses of several cytokines and growth factors (Aaronson
and Horvath, 2002). Elevation in both total and p-STAT3 indicates activation of STAT-3 signaling (Sehgal, 2008). Because ele-
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Figure 4. NBQX treatment reduces Ca 2⫹ influx in O4 ⫹ cells treated with plasma and minimizes apoptosis and promotes maturation of OPC in rabbits with IVH. A, Representative image of the
Fluo-Forte-labeled O4 ⫹ cells exposed to plasma or plasma with NBQX. Quantification of mean fluorescence intensities is represented as mean ⫾ SEM (n ⫽ 5). B, Representative images of TUNEL
(green) and O4 immunostaining for OPCs (red) in the corona radiata, as indicated. Insets, High-magnification views. TUNEL ⫹ OPCs were reduced in NBQX-treated pups with IVH compared with
vehicle controls. C, A typical image of cryosections (D3 pup) double-labeled with PDGFR␣- and Ki67-specific antibodies. Graphs represent mean ⫾ SEM (n ⫽ 5 each). Total (both cycle and
noncycling) PDGFR␣ ⫹ cells are comparable in the three groups, as indicated. Cycling PDGFR␣ ⫹ cells are reduced in pups with IVH, and NBQX treatment shows an insignificant trend toward increase
in the density of these cells compared with vehicle controls. D, Representative images of cryosections of D7 pup double-labeled with Olig2- and Nkx2.2-specific antibodies. Quantification represents
mean ⫾ SEM (n ⫽ 5 each). Note an increase in Nkx2.2 ⫹Olig2 ⫹ cells in NBQX-treated pups relative to vehicle controls. *p ⬍ 0.05, pups with versus without IVH. **p ⬍ 0.001, pups with versus
without IVH. #p ⬍ 0.05, vehicle versus NBQX-treated pups with IVH. ##p ⬍ 0.001, vehicle versus NBQX-treated pups with IVH. Scale bar, 50 m.

vated levels of several proinflammatory cytokines in pups with
IVH were substantially reduced by NBQX treatment, we postulated that the IVH might induce STAT3 phosphorylation and
that NBQX treatment could suppress the STAT3 activation. To
this end, we compared levels of STAT and p-STAT (tyrosine 705
and serine 707) in control pups without IVH, vehicle-, and
NBQX-treated pups with IVH at D3. We found that IVH enhanced total STAT ( p ⬍ 0.05) and phosphorylation of tyrosine
residues in STAT3 species ( p ⬍ 0.001), but not of serine. More
importantly, NBQX treatment reduced phosphorylation of tyrosine (tyrosine 705) in STAT3 protein in pups with IVH ( p ⬍
0.001; Fig. 7A). Elevation in both total and p-STAT3 indicates
their activation (Sehgal, 2008). To determine the specific neural
cell type undergoing STAT-3 phosphorylation, we doublelabeled the brain sections with p-STAT3 and Olig2, GFAP, or
Sox2 antibodies. We found that p-STAT-3 ⫹ cells were more
abundant in rabbits with IVH compared with controls without
IVH and NBQX-treated pups (Fig. 7B). Importantly, p-STAT-3
was abundantly expressed on Sox2 ⫹ cells of the ventricular zone
and subventricular zone and also on several Olig-2 ⫹, GFAP ⫹,

and S100␤ ⫹ cells of the periventricular white matter of pups with
IVH (Fig. 7B). This suggests that STAT-3 phosphorylation involves Sox2 ⫹ progenitors and also cells of both astrocytic and
oligodendroglial lineage.
JAK-STAT pathway is activated in brain disorders, including
ischemia, degeneration, and cancer, and regulates expression of
genes related to cell survival, proliferation, and differentiation
(Cattaneo et al., 1999). STAT signaling also plays key role in
astrogliosis (Herrmann et al., 2008). Because IVH increased
GFAP expression and as NBQX inhibited STAT3 activation, we
postulated that NBQX treatment might attenuate astrocyte proliferation and affect transcription factor regulating astrocytes, including NFIA and Sox9. To this end, we (1) evaluated astrocyte
proliferation by double immunolabeling section with S-100␤ and
ki67 antibodies and (2) quantified expression of NFIA and Sox9
transcription factor at D3. We found that NBQX treatment neither affected proliferation of S100 ␤ ⫹ astrocytes (data not
shown) nor significantly influenced protein or mRNA expression
of NFIA and Sox9 expression (Fig. 7B; qRT-PCR data not shown).
Moreover, NICD protein and Hes1 mRNA expression were not
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Figure 5. NBQX suppresses microglia infiltration and production of proinflammatory cytokines. A, Representative images of cryosections form the corona radiata stained with Iba-1-specific
antibody and sytox (nuclear stain) of D3 pups. Insets, High-magnification views of the boxed area in the image. Iba-1 ⫹ microglia (arrow) are more abundant in pups with IVH relative to controls
without IVH, and NBQX treatment reduces their density. Scale bar, 50 m. B, Data are mean ⫾ SEM (n ⫽ 5 each group), showing data from corona radiata and germinal matrix (GM). C, TNF␣, IL1␤,
IL-6, and LIF mRNA levels were elevated in pups with IVH compared with controls without IVH at D3, and NBQX treatment reduced these levels in pups with IVH. Interferon (IFN) ␥ and CNTF gene
expression was similar between groups. Data are mean ⫾ SEM (n ⫽ 5 each group). *p ⬍ 0.05, pups with versus without IVH. **p ⬍ 0.01, pups with versus without IVH. ***p ⬍ 0.001, pups with
versus without IVH. #p ⬍ 0.05, vehicle versus NBQX-treated pups with IVH. ##p ⬍ 0.01, vehicle versus NBQX-treated pups with IVH. ###p ⬍ 0.001, vehicle versus NBQX-treated pups with IVH.

substantially affected by the development of IVH and subsequent
NBQX treatment (Fig. 7B; data not shown), indicating a lack of
effect of NBQX on Notch signaling pathways. Together, IVH
activates STAT-3 phosphorylation, which is abrogated by NBQX
treatment. A failure of NBQX treatment to affect astrocyte proliferation and astrogliosis suggests that pathways other than
STAT-3 activation, such as bone morphogenetic protein and
transforming growth factor ␤, might be playing an important
role in the IVH-induced gliosis.
Effect of FDA-approved perampanel on myelination, gliosis,
and neurobehavior
NBQX is known to offer neuroprotection in numerous animal
models of brain injury (Pulsinelli et al., 1982; Choi, 1995; Goda et
al., 2002; Groom et al., 2003), but it has not been approved for
clinical use in patients because of its adverse effects. By contrast,
perampanel is a noncompetitive inhibitor of AMPA receptors
and has been approved by FDA for use as an antiepileptic in
patients with partial-onset seizures. Because perampanel is a safe
and specific AMPA inhibitor and can potentially be used in infants with IVH, we evaluated the effect of intramuscular perampanel treatment in pups with IVH starting at D1. To this end, we
compared myelination and astrogliosis in pups without IVH,

perampanel-treated pups with IVH, and vehicle controls. Stereological quantification of MBP in immunolabeled sections revealed that the volume fractions of MBP in the corpus callosum
and corona radiata were significantly higher in perampaneltreated pups with IVH compared with vehicle controls ( p ⫽
0.004; Fig. 8A). Accordingly, Western blot analyses demonstrated
that MBP and MAG levels were reduced in pups with IVH relative
to controls without IVH ( p ⬍ 0.001 each) and that perampanel
treatment significantly increased MBP and MAG levels in pups
with IVH ( p ⫽ 0.001 each; Fig. 8 B, C).
We next evaluated GFAP expression in the above sets of pups. We
found that GFAP expression was higher in IVH pups relative to
controls without IVH both on stereological quantification of immunostained sections and Western blot analyses (p ⫽ 0.006 and p ⫽
0.01, respectively), and perampanel treatment did not affect the
GFAP expression in pups with IVH. Likewise, the development of
IVH elevated vimentin expression on Western blot analyses (p ⬍
0.001), and perampanel treatment did not affect its levels.
We next compared neurobehavioral performance of perampanel- and saline-treated pups with IVH (n ⫽ 8 each). The
two groups were comparable with respect to the severity of IVH.
All glycerol-treated pups without IVH were neurologically normal. In contrast, we found symmetric quadriparesis in one pup
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Figure 6. NBQX treatment does not alter GFAP expression. A, Representative immunofluorescence of GFAP in the cryosections from D14 pups, as indicated. Abundant hypertrophic astrocytes
were observed in vehicle- and NBQX-treated pups with IVH. Scale bar, 50 m. Inset, High-power view of astrocytes. Data are mean ⫾ SEM (n ⫽ 5 each). NBQX treatment did not affect volume
fraction of astroglial fibers compared with vehicle controls on stereological analyses on D14. B, Western blot analyses for GFAP were performed in forebrain homogenates of pups at D3. Adult rat brain
was positive control. Data are mean ⫾ SEM (n ⫽ 5 each). Values were normalized to ␤-actin. IVH increased GFAP levels, and NBQX treatment did not affect GFAP expression in pups with IVH. C,
Western blot analyses for GFAP were performed in forebrain homogenates of pups (D14). Adult rat brain was positive control. Data are mean ⫾ SEM (n ⫽ 5 each). Values were normalized to ␤-actin.
IVH increased GFAP levels, and NBQX treatment did not affect GFAP expression in pups with IVH. *p ⬍ 0.05, no IVH versus IVH. **p ⬍ 0.01, no IVH versus IVH. ***p ⬍ 0.001, no IVH versus IVH.

(12.5%), and left/right leg weakness (monoparesis, 25%) in
two saline-treated pups. The pup with quadriparesis was completely unable to walk, and pups with monoparesis manifested
with clumsy gait. All perampanel-treated pups were neurologically normal. The scores for gait were significantly higher in
perampanel-treated pups compared with saline controls ( p ⬍
0.05). The percentage of pups showing inability to hold their
position on a ramp pitched at 60° inclination for ⱖ20 s was
significantly higher in NBQX-treated pups compared with the
saline controls. Scores for the righting reflex and hind arm movement were superior in perampanel-treated pups compared with
saline controls ( p ⬍ 0.05, all). There was no significant difference
in sensory and cranial nerve assessment of the three sets of rabbit
pups. Importantly, we did not observe any apparent adverse effect attributable to perampanel treatment among pups with IVH.
There was also no significant difference in the temperature between groups, similar to NBQX-treated pups.

Discussion
IVH occurs in ⬃12,000 premature infants every year in the
United States. Because survival rates of premature infants have
strikingly improved, neurologic sequelae of IVH have emerged as
important public health concerns. Yet, no effective therapy exists
to prevent the white matter injury in the survivors of IVH. In the

present study, we found that AMPA-kainate receptor inhibition
alleviated IVH-induced inflammation, reduced calcium signaling in OPCs, restored maturation of OPCs, and promoted myelination and neurologic recovery in preterm rabbits with IVH.
Similar restoration of myelination and neurological function
were observed with the AMPA-kainate antagonist NBQX and the
FDA-approved AMPA-specific inhibitor perampanel. Hence, the
present study highlights the role of AMPA-kainate receptor in
IVH-induced white matter injury and identifies a novel strategy
of neuroprotection in premature newborns with IVH.
The most important and novel observation in this study was
that AMPA-kainate receptor inhibition reduced apoptosis of
OPCs, enhanced OPC maturation, and promoted myelination in
a rabbit model of IVH. To our knowledge, this is the first demonstration that AMPA-kainate inhibition protects OPCs and
improves myelination in an animal model of IVH. However, a
number of studies have examined the neuroprotective role
of AMPA-kainate antagonists in animal models of neonatal
hypoxia-ischemia, perinatal inflammation, and multiple sclerosis (Fern and Möller, 2000; Follett et al., 2000, 2004; Deng et al.,
2003; Kanwar et al., 2004). Consistent with our study, treatment
with NBQX and the anticonvulsant topiramate reduces oligodendrocyte death and enhances myelination in rodent model of
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Figure 7. NBQX blocks p-STAT3 signaling. A, Representative Western blot analysis for total STAT3, pSTAT3 (Tyr), and pSTAT3 (Ser) levels in the brain homogenates from preterm rabbits as
indicated. Adult rat brain was positive control. Values were normalized to ␤-actin. Data are mean ⫾ SEM (n ⫽ 5 each). Total STAT-3 and pSTAT(Tyr) levels were significantly increased in pups with
IVH compared with pups without IVH, which were significantly reduced by NBQX treatment. However, pSTAT3 (Ser) expression was comparable between groups. B, Representative immunofluorescence of cryosections from 3-d-old E29 pup double-labeled with p-STAT-3 and Olig2-, GFAP-, or Sox2-specific antibodies. p-STAT-3 was expressed more abundantly in IVH pups compared with
controls without IVH. Also, Sox2 ⫹, Olig-2 ⫹, GFAP ⫹, and S100␤ ⫹ cells (arrowhead) coexpress p-STAT3 in the periventricular white matter. Inset, High-power view of the boxed area in the image.
Scale bar, 20 m. C, Representative Western blot analysis for nuclear factor 1 A (NFIA), Sox9, and NICD expression in the brain homogenates from preterm rabbits, as indicated. Values were
normalized to ␤-actin. Data are mean ⫾ SEM (n ⫽ 5 each). NFIA, Sox9, and NICD levels were comparable between groups, as indicated.

neonatal hypoxia-ischemia (Follett et al., 2004). NBQX improves
survival of OPCs and remyelination as well as reduces axonal
damage resulting in amelioration of disease process in animals
models of multiple sclerosis (Groom et al., 2003; Kanwar et al.,
2004). However, systemic NBQX treatment has failed to reduce
apoptosis of OPCs in a neonatal model of the IL-6␤-induced
white matter injury (Cai et al., 2004). The role of AMPA-kainate
receptors has also been previously evaluated in oligodendrocyte
culture experiments. Primary OPC cultures under the conditions
of oxygen-glucose deprivation have shown activation of Ca 2⫹permeable AMPA receptors and NBQX treatment has offered
cytoprotection, suggesting AMPA-kainate receptors to be a major mechanism of OPC injury (Follett et al., 2000; Tekkök and
Goldberg, 2001; Deng et al., 2003). Among cells of oligodendrocyte lineage, mature oligodendrocytes are less vulnerable to injury compared with immature OPCs and preoligodendrocytes
(Fern and Möller, 2000; Follett et al., 2000). Together, AMPAkainate inhibition might offer an important strategy of neuroprotection in premature infants with IVH.
Although we observed neuroprotection with NBQX treatment, this agent exhibits renal toxicity and is not in clinical use.

Therefore, we tested perampanel, an FDA-approved antiepileptic
drug, in our model, which showed similar effects in enhancing
myelination and neurological recovery as NBQX treatment. Perampanel is a potent, noncompetitive, and selective AMPA receptor antagonist and a broad-spectrum anticonvulsant (Hanada et
al., 2011). It has low side-effect profile and lacks psychomimetic
properties because it does not interact with NMDA receptors
(Rogawski, 2011). Moreover, it has an attractive pharmacokinetic profile. For example, it has a long half-life, allowing oncedaily dosing, and interaction to other antiepileptic drugs is
limited to oxycarbazepine (Hanada et al., 2014). Dizziness and
somnolence are the common adverse effects in adult patients.
Perampanel has shown efficacy and safety in Phase III clinical
trials for partial seizures in a dose of 8 and 12 mg (Gidal et al.,
2015; Vazquez et al., 2015). In the present study, we treated rabbits with perampanel at 18 –20 h after the induction of IVH.
Because 90% of all IVH occur within 72 h of birth and as preterm
infants in neonatal units undergo screening head ultrasound to
detect IVH during this period, it is feasible to initiate perampanel
treatment on these infants shortly after the development of IVH.
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Figure 8. Perampanel treatment restores myelination in rabbits with IVH. A, Representative immunofluorescence of MBP in the corona radiata of D14 pups. Data are mean ⫾ SEM (n ⫽ 5 each
group). Volume fractions of MBP were higher in the corpus callosum and corona radiata of perampanel-treated pups compared with vehicle controls with IVH. Scale bar, 200 m. V, Ventricular side.
B, Typical Western blot analysis for MBP expression in the forebrain of premature rabbit pups, as indicated, at D14. Adult rat brain was used as positive control. Each lane represents one brain. Bar
chart represents mean ⫾ SEM (n ⫽ 5 each group). MBP abundance was higher in perampanel-treated pups compared with vehicle controls. C, Western blot analysis of MAG expression in the
forebrain of pups as indicated at D14. Bar graph represents mean ⫾ SEM (n ⫽ 5 each group). MAG expression was higher in perampanel-treated pups compared with vehicle controls. ***p ⬍ 0.001,
pups with versus without IVH. #p ⬍ 0.05, vehicle versus parempanel-treated pups with IVH. ###p ⬍ 0.001, vehicle versus parempanel-treated pups with IVH. D, Representative immunofluorescence of corona radiata from cryosections labeled with GFAP antibody, as indicated. Note abundant hypertrophic astrocytes in vehicle- and NBQX-treated pups with IVH. Scale bar, 50 m. Data are
mean ⫾ SEM (n ⫽ 5 each). Perampanel treatment did not affect volume fraction of astroglial fibers compared with vehicle controls on stereological analyses. E, F, Western blot analyses for GFAP
and vimentin were performed in forebrain homogenates of pups (D14). Adult rat brain was positive control. Data are mean ⫾ SEM (n ⫽ 5 each). Values were normalized to ␤-actin. Vimentin and
GFAP levels were elevated in pups with IVH compared with pups without IVH. Perampanel treatment did not affect GFAP or vimentin expression. *p ⬍ 0.05, no IVH versus IVH. **p ⬍ 0.01, no IVH
versus IVH. ***p ⬍ 0.001, no IVH versus IVH.

Together, our findings justify consideration of perampanel treatment in preterm infants with IVH.
We demonstrated that AMPA-kainate blockade suppressed inflammation. Specifically, we noted that NBQX treatment reduced
apoptotic OPC death, microglia infiltration, and production of proinflammatory cytokines, including TNF␣, IL1␤, LIF, and IL-6. It
appears that NBQX treatment reduced cell death by attenuating
Ca 2⫹ levels in the OPCs and consequently diminished microglia
infiltration in the white matter of rabbits with IVH. Importantly,
microglia express GluR2–5, GluR7, KA1, and KA2 receptors; and
activation of their Glu receptors triggers release of TNF-␣ (Noda et
al., 2000; Hagino et al., 2004). Other proinflammatory cytokines
(IL-1␤ and interferon-␥) are also produced primarily by microglia
or T-lymphocytes in conditions of brain injury. LIF is an IL-6 class
cytokine that inhibits cell differentiation. Hence, we speculate that
downregulation of LIF, TNF␣, and IL1␤ with NBQX treatment
might have promoted maturation of OPCs in rabbits with IVH

(Falahati et al., 2013; Rittchen et al., 2015). Because AMPA inhibition also blocks TNF␣- and IL1␤-induced oligodendrocyte and neuronal death (Hermann et al., 2001; Takahashi et al., 2003),
downregulation of cytokines by NBQX treatment in our rabbit pups
might have reduced apoptosis of OPC after IVH. NBQX has been
shown to induce protective hypothermia (Nurse and Corbett, 1996).
However, we observed no difference in the rectal temperature between NBQX-treated and vehicle controls, which is consistent with
the other studies (Hagberg et al., 1994; Follett et al., 2000). Thus,
activation of AMPA receptors contributed to apoptotic cell death,
microglial infiltration, and release of cytokines; and NBQX treatment seemingly ameliorated inflammation, reduced release of
TNF␣ and IL-1␤ from microglia, and consequently enhanced survival and maturation of OPCs.
Composition of AMPA receptors, particularly the expression of
GluR2 subunit, has a critical impact on AMPA-mediated toxicity,
and the relative expression of the AMPA subunits alters during brain
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development and in brain pathologies (Pellegrini-Giampietro et al.,
1992). AMPA receptor composition has been evaluated in the embryonic white matter of human fetuses and preterm infants of
18 – 46 gestational weeks (Talos et al., 2006a, b). GluR1 expression
remains above adult level and does not change significantly with
advance in gestational age. In contrast, GluR2 expression in the embryonic brain is ⬃40%-60% of the adult level and gradually increases as gestational age advances. GluR3 and GluR4 levels are
several-fold higher in preterm infants and gradually drops to adult
level by the end of pregnancy. In the present study, we did not find
any difference in the expression of GluR1-GluR4 in infants with and
without IVH in our analyses of human samples. However, we made
an important observation that GluR1 and GluR2 were significantly
reduced in periventricular white matter and germinal matrix compared with the cortex. Because the presence of GluR2 subunit renders AMPA receptors impermeable to Ca 2⫹, diminished expression
of GluR2 in white matter and germinal matrix can increase their
vulnerability to Ca 2⫹-induced injury, unlike the cortical mantle.
Conversely, a reduction in GluR1 expression will decrease Ca 2⫹ permeability and diminish glutamate-induced excitotoxicity. Thus, the
ratio of GluR1 and GluR2 expression in IVH is likely to determine
the Ca 2⫹ permeability and subsequent neurotoxicity.
JAK-STAT3 pathways regulate cell survival, proliferation, and
differentiation (Aaronson and Horvath, 2002). They are active during periods of neuronal and glial differentiation and are stimulated
by cytokines (Cattaneo et al., 1999). STAT3 is expressed by astrocytes
and OPCs and plays a key role in mediating astrogliosis in models of
spinal cord injury, traumatic brain damage, and cerebral infection
(Na et al., 2007; Herrmann et al., 2008; Zhao et al., 2011). Accordingly, we found increased phosphorylation (tyrosine 705) and elevated total levels of STAT-3 in pups with IVH and restoration after
NBQX treatment. However, NBQX treatment did not affect proliferation of astrocytes, GFAP expression, or the levels of transcription
factors regulating astrocytes (NFIA and SOX9) in our model of IVH.
Previous study in a paradigm of neuropathic pain has shown that
JAK-STAT3 activation increases astrocyte proliferation. STAT-3
knock out animals also exhibit reduced GFAP expression in several
models of brain injury (O’Callaghan et al., 2014). Coculture studies
of neural stem cells and microglia have demonstrated that STAT-3
activation increases astrogliosis via Notch and Sox9 signaling pathway (Zhu et al., 2008). Together, AMPA blockade did not affect
astrogliosis despite inhibition of STAT-3 signaling, which indicates
that other signaling pathways (Notch, bone morphogenetic protein,
or transforming growth factor ␤) might also be contributing to IVHinduced astrogliosis.
In conclusion, this study discovered previously an unknown role
of AMPA-kainate receptors in IVH-induced hypomyelination and
identified a novel strategy to restore myelination in the survivors of
IVH. Reduced GluR2 expression in the OPCs of the white matter
and germinal matrix likely contributed to their high propensity to
IVH-induced injury. More importantly, AMPA-kainate inhibition
by NBQX treatment suppressed inflammation, reduced apoptosis of
OPCs, enhanced their maturation and myelination, and promoted
neurologic recovery. AMPA receptor-specific inhibitor perampanel,
an FDA-approved drug, was also found to restore myelination of the
white matter and neurological function; therefore, perampanel
treatment might improve the neurological outcome of preterm infants with IVH.

References
Aaronson DS, Horvath CM (2002) A road map for those who don’t know
JAK-STAT. Science 296:1653–1655. CrossRef Medline
Back SA, Luo NL, Borenstein NS, Levine JM, Volpe JJ, Kinney HC (2001)

Dohare et al. • AMPA-Kainate Receptor Inhibition and IVH
Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury. J Neurosci
21:1302–1312. Medline
Back SA, Han BH, Luo NL, Chricton CA, Xanthoudakis S, Tam J, Arvin KL,
Holtzman DM (2002) Selective vulnerability of late oligodendrocyte
progenitors to hypoxia-ischemia. J Neurosci 22:455– 463. Medline
Ballabh P (2010) Intraventricular hemorrhage in premature infants: mechanism of disease. Pediatr Res 67:1– 8. CrossRef Medline
Ballabh P, Xu H, Hu F, Braun A, Smith K, Rivera A, Lou N, Ungvari Z,
Goldman SA, Csiszar A, Nedergaard M (2007) Angiogenic inhibition
reduces germinal matrix hemorrhage. Nat Med 13:477– 485. CrossRef
Medline
Bystron I, Blakemore C, Rakic P (2008) Development of the human cerebral
cortex: Boulder Committee revisited. Nat Rev Neurosci 9:110 –122. CrossRef
Medline
Cai Z, Lin S, Pang Y, Rhodes PG (2004) Brain injury induced by intracerebral injection of interleukin-1beta and tumor necrosis factor-alpha in the
neonatal rat. Pediatr Res 56:377–384. CrossRef Medline
Cattaneo E, Conti L, De-Fraja C (1999) Signalling through the JAK-STAT
pathway in the developing brain. Trends Neurosci 22:365–369. CrossRef
Medline
Choi DW (1995) Calcium: still center-stage in hypoxic-ischemic neuronal
death. Trends Neurosci 18:58 – 60. CrossRef Medline
Chua CO, Chahboune H, Braun A, Dummula K, Chua CE, Yu J, Ungvari Z,
Sherbany AA, Hyder F, Ballabh P (2009) Consequences of intraventricular hemorrhage in a rabbit pup model. Stroke 40:3369 –3377. CrossRef
Medline
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